Directorate Change

RNS Number : 5632G

Shanks Group PLC

02 July 2012

Shanks Group plc

Appointment of New Group Finance Director

The Board of Shanks Group plc ("Shanks" or "the Group"), one of Europe's leading waste management businesses, is pleased to announce the appointment of Toby Woolrych as Group Finance Director with effect from 27 August. Chris Surch will step down from the Board on 26 August and leave the Group on 31 August to join FirstGroup, as announced on 14 May.

Toby joins from Consort Medical plc where he has been Finance Director since 2008. He was previously Chief Financial Officer and Chief Operating Officer at Acta SpA, a renewable energy company.

Toby began his career at Arthur Andersen where he qualified as a Chartered Accountant before becoming Finance Director of Medicom International Ltd, a medical publishing company, in 1992. He joined Johnson Matthey plc as Corporate Development Manager in 1997, going on to become divisional Finance Director and then Managing Director of one of Johnson Matthey's global speciality chemicals business units.

Peter Dilnot, Group Chief Executive of Shanks, commented:

"I am delighted to welcome Toby to the Board. His experience as Finance Director of two listed companies, as well as his strong operational and financial expertise in the renewable energy sector will be of great benefit to Shanks as we accelerate our investment strategy across our businesses. I am very much looking forward to working with him.

"I would also like to take this opportunity to thank Chris for the contribution he has made to the development of Shanks over the last three years, and for all his support since I joined the Group."

Toby Woolrych, Group Finance Director (designate) added:

"I am delighted to be joining Shanks at this stage of the Group's development. Shanks is a unique business with strong market positions and a compelling long term strategy for growth. This is an exciting time for the Group and I look forward to working with Peter and the rest of the management team to deliver the next stage of Shanks' growth."

Shanks confirms that there is no further information to be disclosed under paragraph 9.6.13 of the listing rules with regard to this appointment.

2 July 2012

Enquiries: